Global nerve repair and regeneration market to reach $25.67 billion by 2032 with 12.19% CAGR.

From GlobeNewswire: 2025-07-02 09:22:00

The global Nerve Repair and Regeneration Market was valued at USD 9.14 billion in 2023, projected to reach USD 25.67 billion by 2032 with a 12.19% CAGR. Innovations in neurostimulation and biomaterials are transforming peripheral nerve injury treatment with more targeted approaches. The U.S. market is estimated to reach USD 6.45 billion by 2032. Biosimilar erythropoietin products are gaining traction in the U.S., driving market growth. Major players in the market include Axogen Inc., Integra LifeSciences, and Synovis Micro Companies Alliance. The neurostimulation and neuromodulation devices segment is anticipated to hold the largest share in the market. The Nerve Repair and Regeneration Market is expected to register the fastest growth in Asia-Pacific, with North America dominating the market in 2023. Asia-Pacific is estimated to grow at the highest CAGR due to rising chronic kidney disease and cancer prevalence.



Read more at GlobeNewswire: Nerve Repair and Regeneration Market to Reach USD 25.67